Moderna, Inc. ( MRNA) - Key Metrics
MRNA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.73 | -$2.11 | $2.43 | $2.33 |
| 2025Q3 | $2.61 | -$0.51 | -$2.17 | -$2.26 |
| 2025Q2 | $0.37 | -$2.13 | -$2.37 | -$2.38 |
| 2025Q1 | $0.28 | -$2.52 | -$2.69 | -$3.02 |
MRNA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -3.50 |
| 2025Q3 | ? | -12.59 |
| 2025Q2 | ? | -3.24 |
| 2025Q1 | ? | -2.82 |
MRNA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -3.45% | ? |
| 2025Q4 | 7.89% | ? |
| 2025Q3 | -8.74% | ? |
| 2025Q2 | -8.61% | ? |
| 2025Q1 | -10.64% | ? |
MRNA
Price: $54.05
52 week price:
Payout Ratio Range:
Earnings Per Share: -8.14 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.3 million
Market Capitalization: 31.6 billion